Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0600139 (
Prostate Cancer
)
4,540
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MRI
, because of its multiplaner capability and high soft tissue contrast, is ideally suited for examination of the prostate. The normal prostatic zonal architecture and periprostatic anatomy can be visualized. The use of an endorectal surface coil greatly enhances resolution. Clinical application to the study of BPH, prostate
carcinoma, prostatic
cysts, and inflammatory disease is discussed.
MRI
appears to be emerging as the modality of choice for imaging the prostate.
...
PMID:Magnetic resonance imaging of the prostate gland. 170 May 26
Prostate carcinoma
is the most common cancer in men and the second most lethal malignancy among the American male population. Nevertheless, it is potentially curable if detected early and treated appropriately. Treatment options vary depending on the extent (stage) of the cancer.
MRI
has no role as a screening method for prostatic carcinoma because it is expensive, time consuming, and unable to differentiate benign from malignant disease, but it can detect early prostatic cancers in patients with known tumor and can accurately stage these tumors.
MRI
is becoming the imaging modality of choice for local staging of prostate cancer and is rapidly replacing CT and ultrasonography for this purpose. Treatment protocols for bladder carcinoma also depend on the stage of the tumor. Clinical staging of bladder cancer has been limited.
MRI
is as good as or better than CT in bladder tumor staging when extravesical tumor involvement is present.
MRI
also has the potential to become useful in determining the depth of wall invasion in tumors confined to the bladder.
...
PMID:Magnetic resonance imaging of the prostate and bladder. 218 60
A pilot study of
MRI
was carried out on three normal male volunteers and 15 patients with tumours in the prostate or bladder. One advantage of the method is the ability to obtain images in three planes, without moving the patient. It is therefore possible for the first time to demonstrate lesions in the base of the bladder in their cranio-caudal extent. Tissue contrast of
MRI
, using long sequences with suitable proton or T2-weighted images is better than with CT and provides more accurate diagnosis. Even non-expansive tumours within the gland can be differentiated from normal glandular tissue. It has been noted that
carcinoma of the prostate
in the T2-mode provides an increased signal, whereas tumours of the bladder look dark. Up to a point, tissue characterisation may be possible.
...
PMID:[Nuclear spin tomography of the male pelvis. Methods, anatomy and initial clinical results]. 241 16
A total of 7 healthy volunteers and 31 patients have been examined clinically, by
MRI
, TRS, and biopsy. In those patients with established carcinoma, a CT examination was also performed. For the
MRI
study, a superconducting MR 2000 imager (Picker International) operated at 0.15 T was used with multiplanar SE and IR sequences. SE sequences with long echo times detected prostatitis, adenoma and
carcinoma of the prostate
with a high degree of sensitivity. However, at present, differentiation between adenoma, prostatitis and carcinoma is not possible with sufficient accuracy. In these studies we were unable to establish a correlation between the signal pattern and staging and/or grading of the carcinoma. Reliable diagnosis of a prostate carcinoma still requires a biopsy. Because of the high soft tissue contrast and the possibility of selecting any orientation for the plane under investigation, however,
MRI
represents an improvement in the preoperative diagnosis of local spread.
...
PMID:Magnetic resonance (MR) imaging of prostatic tumours, a comparison with X-ray CT and transrectal sonography (TRS). 245 10
Diseases of the prostate are of high socioeconomic importance owing to their high incidence and prevalence rates. Benign prostatic hyperplasia (BPH) can be detected in 80% of males over the age of 80. Clinical symptoms do not correlate with organ enlargement. Only 10% of patients with BPH need surgical treatment. The decision for surgical treatment is made as a result of objective findings and the symptoms reported by the patient. Preoperative evaluation of BPH must include digital rectal examination (DRE), measurement of peak flow rate, sonographic estimation of residual urine, transrectal ultrasound (TRUS), urethrocystography and the assessment of subjective complaints using symptom scores.
Prostatic carcinoma
is the most common malignancy in men. An abnormal DRE, increased PSA level and/or hypoechogenic lesions in TRUS are indications for prostate biopsy. The sensitivity of TRUS is superior to that of CT and
MRI
. New
MRI
techniques are promising with regard to local tumour extent. Whereas CT and
MRI
are not useful in screening of patients, these methods are valuable diagnostic tools in the follow-up of prostate cancer.
...
PMID:[The value of diagnostic imaging in benign prostatic hyperplasia and prostatic cancer]. 751 94
We report two cases of small cell
carcinoma of the prostate
and describe the CT and
MRI
findings, which were primarily based on the rapid growth and high metastatic potential of the tumor. CT and
MRI
are extremely useful for demonstration of metastatic lesions. Histological confirmation is needed if the findings of CT or
MRI
are unusual for ordinary adenocarcinoma of the prostate.
...
PMID:Small cell carcinoma of the prostate: CT and MRI findings. 756 6
Spatial resolution of
MRI
within the true pelvis can be increased by a factor of 12 using an endorectal coil. The value of this new method for demonstrating the prostate, the rectum, the cervix and vagina and of pathological processes of these organs was examined in 89 patients and the results compared with conventional body coil
MRI
. In 25 patients who underwent radical surgery the results of the preoperative studies were compared with the histological findings. Detailed recognition of anatomical structures was markedly improved by using the endorectal coil. Diagnosis of
carcinoma of the prostate
and extension of the tumour was accurately assessed in 33 patients. Preoperative staging was correct in 87%, compared with 73% when using a body coil. The difference was less marked in examinations for carcinomas of the rectum, the cervix and vagina. Nevertheless, staging was more accurate in a few cases with a better recognition of recurrences.
MRI
with endorectal coils will have an important role in diagnosis of carcinomas of the prostate in the future. Its use in the diagnosis of carcinomas of the rectum and cervix must be subject to further studies.
...
PMID:[High-resolution magnetic resonance tomography of the lesser pelvis using an endorectal coil]. 801 1
Samples of metastatic prostate cancer to bone are difficult to obtain. The aim of this study was to compare the results of bone marrow aspirate and trephine biopsy for obtaining metastatic hormone-refractory prostate cancer (HRPC) samples using previous diagnostic planar 99(m)Tc-HDP bone scans to guide the procedure. All samples taken were for the purposes of research and molecular studies on HRPC. Twenty patients with HRPC had bone marrow aspirate and trephines taken from lesions in the posterior superior iliac spine or sacro-iliac region when shown on diagnostic 99(m)Tc-HDP bone scans. Three patients also underwent plain X-ray, 18F-positron emission tomography bone scan, pelvic
MRI
scan and 99(m)Tc nanocolloid bone marrow scans. These images were used to assess if the extra imaging information provided, such as three-dimensional localisation of the bone metastases, was of value for target bone metastases. Cancer cells were obtained in 15/20 (75%) cases in which a trephine biopsy was attempted and 0/20 of cases in which a bone marrow aspiration was attempted. The additional information provided by the range of other imaging investigations was of little benefit in obtaining tumour samples, but did suggest why negative biopsies were obtained in some cases after targeting with planar bone scans. We recommend the use of bone marrow trephine biopsy alone, guided by previous diagnostic 99(m)Tc planar bone scan as a practical method to obtain prostate cancer cells from bone metastases.
Prostate Cancer
Prostatic Dis 2002
PMID:The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer. 1249 5
A 67-year-old man presented with worsening headaches and gait disturbance, and with minimal clinical signs. A brain
MRI
showed multiple solid cerebellar metastases. The pathological diagnosis of metastatic
carcinoma of the prostate
was further suggested by an elevation in prostate specific antigen, and was pathologically confirmed following the neurosurgical removal of the tumours. The rarity of this presentation, as documented in the clinical literature, is reviewed.
...
PMID:Cerebellar metastases from prostatic carcinoma. 1534 3
Prostatic carcinoma
accounts for only 3.6% of orbital metastases encountered in clinical practice. We report the clinical presentation and response to treatment of a patient with metastatic prostatic carcinoma to the sella turcica. A 73-year-old man presented with a three-months history of progressive right proptosis associated with increasing diplopia in down-gaze and slightly decreased visual acuity. Gadolinium-
MRI
scans of the head revealed a left osteoblastic intrasellar mass, displacing the pituitary gland. Laboratory testing revealed a serum PSA level of 22 ng/ml. Transrectal ultrasound-guided biopsy revealed prostatic adenocarcinoma (Gleason score 4+3) in both lobes of the prostate. A bone scan was performed showing that the patient had multiple secondary bony lesions. Total androgen blockade was initiated. Moreover, he was referred for radiotherapy of this metastatic lesion to the sella turcica. The visual complaints regressed dramatically within the first month of the treatment. A follow-up
MRI
scan at 6 months showed almost complete involution of the orbital metastatic process. However the disease subsequently progressed and the patient died 22 months after diagnosis.
...
PMID:Orbital metastasis as a first indication of prostate cancer: a case report. 1614 73
1
2
3
4
Next >>